1. Home
  2. MCD vs LLY Comparison

MCD vs LLY Comparison

Compare MCD & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MCD

McDonald's Corporation

HOLD

Current Price

$273.77

Market Cap

204.6B

ML Signal

HOLD

Logo Eli Lilly and Company

LLY

Eli Lilly and Company

HOLD

Current Price

$1,179.59

Market Cap

979.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCD
LLY
Founded
1940
1876
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.6B
979.6B
IPO Year
1997
2007

Fundamental Metrics

Financial Performance
Metric
MCD
LLY
Price
$273.77
$1,179.59
Analyst Decision
Buy
Strong Buy
Analyst Count
29
19
Target Price
$344.17
$1,218.84
AVG Volume (30 Days)
4.3M
2.0M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
2.56%
0.81%
EPS Growth
4.92
95.99
EPS
2.78
16.19
Revenue
$26,885,000,000.00
$65,179,000,000.00
Revenue This Year
$7.65
$27.15
Revenue Next Year
$6.00
$16.04
P/E Ratio
$99.37
$73.68
Revenue Growth
3.72
44.70
52 Week Low
$260.96
$625.90
52 Week High
$341.75
$1,249.45

Technical Indicators

Market Signals
Indicator
MCD
LLY
Relative Strength Index (RSI) 55.96 55.16
Support Level $271.91 $1,032.70
Resistance Level $278.70 $1,240.73
Average True Range (ATR) 5.20 37.51
MACD 1.12 -4.56
Stochastic Oscillator 86.25 68.09

Price Performance

Historical Comparison
MCD
LLY

About MCD McDonald's Corporation

McDonald's is the world's largest restaurant brand, with nearly $139 billion in systemwide sales across more than 45,000 restaurants and over 100 markets. The quick-service chain built its early reputation on speed, consistency, and affordable hamburgers, and today its global menu spans burgers, chicken, breakfast, and beverages that have helped popularize American fast-food cuisine worldwide. The firm derives the bulk of its revenue from franchise royalties and rent (about 62%), with the remainder stemming from company-operated restaurants across three segments: the United States (39% of systemwide sales), international operated markets (35%), and international developmental/licensed markets (26%).

About LLY Eli Lilly and Company

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Share on Social Networks: